Business Description
European Medical Solutions
ISIN : BE0974497290
Total Employee Number:
127Compare
Compare
Traded in other countries / regions
ALEMS.BelgiumAS00.Germany0RGO.UK IPO Date
2021-02-17Description
European Medical Solutions Formerly DMS Imaging SA is a clinical-stage biopharmaceutical company. The company is engaged in the development and future commercialization of a range of breakthrough immunotherapy products for the treatment of allergies, based on its ASIT+ technology platform. Its lead product is gp-ASIT+, a phase III trial for the treatment of grass pollen rhinitis. Its pipeline products consist of hdm-ASIT+ for the treatment of house dust mite asthma; and pnt-ASIT+ for the treatment of peanut allergy.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.31 | |||||
Equity-to-Asset | 0.23 | |||||
Debt-to-Equity | 1.58 | |||||
Debt-to-EBITDA | 3.94 | |||||
Interest Coverage | 3.63 | |||||
Piotroski F-Score | 6/9 | |||||
Altman Z-Score | 1.75 | |||||
Beneish M-Score | -2.35 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 12.3 | |||||
3-Year Book Growth Rate | 4.3 |
Momentum Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 59.14 | |||||
9-Day RSI | 52.4 | |||||
14-Day RSI | 50.51 | |||||
3-1 Month Momentum % | -2.04 | |||||
6-1 Month Momentum % | 10.73 | |||||
12-1 Month Momentum % | 19.2 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 1.43 | |||||
Quick Ratio | 0.87 | |||||
Cash Ratio | 0.23 | |||||
Days Inventory | 150.57 | |||||
Days Sales Outstanding | 72.19 | |||||
Days Payable | 134.42 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Shareholder Yield % | 0.93 |
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 32.94 | |||||
Operating Margin % | 5.37 | |||||
Net Margin % | 3.69 | |||||
EBITDA Margin % | 9.71 | |||||
FCF Margin % | 5 | |||||
OCF Margin % | 10.77 | |||||
ROE % | 16.44 | |||||
ROA % | 3.62 | |||||
ROIC % | 7.79 | |||||
3-Year ROIIC % | 99.79 | |||||
ROC (Joel Greenblatt) % | 14.32 | |||||
ROCE % | 10.08 | |||||
Years of Profitability over Past 10-Year | 2 |
GF Value Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 11.26 | |||||
PE Ratio without NRI | 11.26 | |||||
Price-to-Owner-Earnings | 9.08 | |||||
PS Ratio | 0.42 | |||||
PB Ratio | 1.72 | |||||
Price-to-Tangible-Book | 24 | |||||
Price-to-Free-Cash-Flow | 8.32 | |||||
Price-to-Operating-Cash-Flow | 3.85 | |||||
EV-to-EBIT | 13.03 | |||||
EV-to-EBITDA | 7.11 | |||||
EV-to-Revenue | 0.69 | |||||
EV-to-FCF | 13.67 | |||||
Price-to-GF-Value | 0.59 | |||||
Price-to-Graham-Number | 3.48 | |||||
Earnings Yield (Greenblatt) % | 7.67 | |||||
FCF Yield % | 11.79 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
European Medical Solutions Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 49.922 | ||
| EPS (TTM) (€) | 0.435 | ||
| Beta | 23.0113 | ||
| 3-Year Sharpe Ratio | 0.58 | ||
| 3-Year Sortino Ratio | 179.85 | ||
| Volatility % | 20.86 | ||
| 14-Day RSI | 50.51 | ||
| 14-Day ATR (€) | 0.228006 | ||
| 20-Day SMA (€) | 4.782 | ||
| 12-1 Month Momentum % | 19.2 | ||
| 52-Week Range (€) | 3.9265 - 5.45 | ||
| Shares Outstanding (Mil) | 4.23 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
European Medical Solutions Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
European Medical Solutions Stock Events
| Event | Date | Price (€) | ||
|---|---|---|---|---|
| No Event Data | ||||
European Medical Solutions Frequently Asked Questions
What is European Medical Solutions(STU:AS00)'s stock price today?
The current price of STU:AS00 is €4.80. The 52 week high of STU:AS00 is €5.45 and 52 week low is €3.93.
When is next earnings date of European Medical Solutions(STU:AS00)?
The next earnings date of European Medical Solutions(STU:AS00) is .
Does European Medical Solutions(STU:AS00) pay dividends? If so, how much?
European Medical Solutions(STU:AS00) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on European Medical Solutions
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers